Hepatic steatosis is defined as pathologically elevated liver fat content and has many
underlying causes. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic …

Hepatic steatosis is a frequently encountered imaging finding that may indicate chronic liver
disease, the most common of which is non-alcoholic fatty liver disease. Non-alcoholic fatty …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Nonalcoholic fatty liver disease (NAFLD) is a frequent cause of chronic liver diseases,
ranging from simple steatosis to nonalcoholic steatohepatitis (NASH)-related liver cirrhosis …

This study aimed to assess the effect of luseogliflozin on liver fat deposition and compare
luseogliflozin to metformin in type 2 diabetes (T2D) patients with non‐alcoholic fatty liver …

Aims In observational studies, non-alcoholic fatty liver disease (NAFLD) is associated with
high risk of ischaemic heart disease (IHD). We tested the hypothesis that a high liver fat …

Abdominal CT is a frequently performed imaging examination for a wide variety of clinical
indications. In addition to the immediate reason for scanning, each CT examination contains …

Background Nonalcoholic fatty liver disease and its consequences are a growing public
health concern requiring cross-sectional imaging for noninvasive diagnosis and …

Purpose: The roles of intravisceral and subcutaneous fat are unknown, and the prevalence
of precancerous lesions in obese patients was never evaluated. This study aims to assess …

Non-alcoholic fatty liver disease (NAFLD) has been an emerging major health problem, and
the most common cause of chronic liver disease in Western countries. Traditionally, liver …